Special Reports:

Our HIV reporting of the past decade

< Back to special reports

A large chunk of our reporting focuses on HIV. Since the launch of Bhekisisa in 2013, we’ve covered HIV in-depth — from the impact of the virus on former president Nelson Mandela’s family to the advances in antiretroviral treatment and anti-HIV pills and injections. We’ve also looked at the impact of inequality and discrimination on the spread of HIV, the link between gender-based violence and HIV — and ways to fix it.

HomeMultimedia What you need to know about SA's new HIV drug

Multimedia Videos Special Reports Our HIV reporting of the past decade

[ICYMI] What you need to know about SA’s new HIV drug

–

November 26, 2019

November 26, 2019

Tomorrow, Health Minister Zweli Mkhize is expected to announce the rollout of a new blockbuster HIV drug called dolutegravir. But the success of the new medication depends on many things, not least of which giving women a real choice when it comes to contraception.

Watch live as activists, officials and experts tell you what you need to know as part of Bhekisisa’s latest policy dialogue.

Don’t forget to follow the conversation on Twitter using the hashtag #HerChoice

Bhekisisa Team

Previous article

If you were a girl: Men, this is what you need to understand about women and violence

Next article

Risks & benefits: New HIV drug combo could change the course of SA’s epidemic

RELATED ARTICLES

MORE FROM AUTHOR

Archives